Mary Beth Amen is a pharmacist who is specialized in Psychiatric in Lincoln, Nebraska. Patients can reach her at 2301 O St Ste 3, Lincoln or contact her on 402-817-0165. Active license number of Mary Beth Amen is 10589 for Psychiatric in Nebraska. Mary Beth Amen is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Mary Beth Amen speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mary Beth Amen
Specialization:
Psychiatric
Credentials:
PHARMD
Gender:
Female
Location:
2301 O St Ste 3, Lincoln, Nebraska, 68510-1100
Phone:
402-817-0165
Fax:
402-417-0255
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mary Beth Amen are as mentioned below.
NPI Number:
1972021228
NPI Enumeration Date:
07 Sep, 2017
NPI Last Update On:
21 Jul, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mary Beth Amen are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
10589
Nebraska
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2301 O St Ste 3, Lincoln, Nebraska
Zip:
68510-1100
Phone Number:
402-817-0165
Fax Number:
402-417-0255
Patients can reach Mary Beth Amen at 2301 O St Ste 3, Lincoln, Nebraska or can call on phone at 402-817-0165.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.